MoonLake Immunotherapeutics (MLTX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.53 | -86.8% |
| 2024 | $-1.89 | -158.9% |
| 2023 | $-0.73 | +57.1% |
| 2022 | $-1.70 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.53 | -86.8% |
| 2024 | $-1.89 | -158.9% |
| 2023 | $-0.73 | +57.1% |
| 2022 | $-1.70 | — |